Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes Observational Safety Change patient management

12 Publications found

Implementation of the European Society of Cardiology 0/3-hour accelerated diagnostic protocol, using high sensitive troponin T: a clinical practice evaluation of safety and effectiveness involving 3003 patients with suspected acute coronary syndrome.

b

Open heart

December 26, 2023

p Cardiovascular Disease

c Change patient management Clinical outcomes Observational Operational efficiencies Safety
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.

b

Journal of neuro-oncology

September 1, 2022

p Cancer

c Change patient management Clinical outcomes Observational Safety
Weight Based Heparin Dosage with Activated Clotting Time Monitoring Leads to Adequate and Safe Anticoagulation in Non-Cardiac Arterial Procedures.

b

Annals of vascular surgery

August 1, 2022

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.

b

BMC medicine

February 1, 2022

p Cancer

c Change patient management Clinical outcomes Observational Safety
Routine fixed-dose heparin vs. ACT-guided heparin administration for elective PCI and its influence on patient in-hospital outcome: a retrospective study.

b

Coronary artery disease

September 1, 2021

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Intelligent Liver Function Testing: Working Smarter to Improve Patient Outcomes in Liver Disease.

b

The journal of applied laboratory medicine

September 1, 2020

p Liver Disease

c Change patient management Clinical outcomes Economics Observational Patient-centeredness Safety
Heparin sensitivity and postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass.

b

European journal of anaesthesiology

March 1, 2020

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.

b

Circulation. Cardiovascular interventions

June 1, 2018

p ACT Guided Heparinization

c Change patient management Clinical outcomes Highlighted Observational Safety
An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population.

b

Journal of cardiothoracic and vascular anesthesia

October 1, 2016

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Off-pump coronary artery bypass grafting using continuous heparin infusion.

b

Indian heart journal

January 1, 2016

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety